QUOTE AND NEWS
Marketwire  Feb 2  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 02/02/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today commented on three recent high profile scientific journal articles that the company believes provide support for Prana's therapeutic strategy for
Marketwire  Jan 11  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 01/11/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that Professor Rudy Tanzi has been appointed as Chief Scientific Advisor to the Company. Professor Tanzi is the Joseph P. and Rose F.
Marketwire  Jan 4  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 01/04/12 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that it has received approval from the United States Food and Drug Administration (FDA) to start recruiting patients for the company's
Marketwire  Dec 16  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 12/16/11 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that the Journal of Biological Chemistry* has published research that provides strong validation of Prana's strategy to treat
Benzinga  Nov 28  Comment 
Prana Biotechnology (NASDAQ: PRAN) today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for a composition of matter patent for selected 8-hydroxy quinazolinone compounds, including its lead...
Marketwire  Nov 22  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 11/22/11 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced that it has received approval from the Austin Health Research Ethics Committee to commence a 12 month Phase II Imaging trial testing
Marketwire  Oct 27  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 10/27/11 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced Associate Professor Kevin Barnham, Principal Research Fellow at The Mental Health Research Institute and Prana scientist, has been
Marketwire  Oct 20  Comment 
MELBOURNE, AUSTRALIA -- (Marketwire) -- 10/20/11 -- Prana Biotechnology (NASDAQ: PRAN) (ASX: PBT) today announced Dr. Paul Adlard, Head of The Synaptic Neurobiology Laboratory at The Mental Health Research Institute and Prana research scientist, has
The Hindu Business Line  Sep 29  Comment 
Caught in a storm over the Finance Ministry's note on the 2G case, the UPA Government went into damage control mode on Thursday. Putting up a show of unity, the Finance Minister, Mr Prana...
StreetInsider.com  Sep 19  Comment 
JinkoSolar (NYSE: JKS) 22.2% LOWER; reports Monday have the plant -- located in Hongxiao, Haining city in eastern Zhejiang province, China -- fouling local air and water. Complaints include waste-water killing large amounts of fish, and toxic...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki